Pinnacle Trial Update

After a forty-two day trial, on March 17, 2016, jurors in the first Pinnacle case rendered $142 million in actual damages and $360 million in punitive damages totaling $502 million dollars for a group of Plaintiffs consisting of Margaret Aoki, Jay Christopher, Donald Greer, Richard Klusmann, and Robert Peterson.  All of the Plaintiffs had Pinnacle [...]

By | September 12th, 2016|Drug and Medical Device Litigation|Comments Off on Pinnacle Trial Update

Is there a Link Between Talcum Powder and Ovarian Cancer?

Recently, there has been increasing medical evidence that suggests that women should not use talcum powder as an intimate hygiene substance because of its links to ovarian cancer. As early as 1971, scientists suggested that there may be a connection with using talcum powder as a hygienic cleanser.  Researchers believed that talc particles could enter [...]

By | August 22nd, 2016|Drug and Medical Device Litigation, Talcum Powder, Uncategorized|Comments Off on Is there a Link Between Talcum Powder and Ovarian Cancer?

FDA Issues Class I Recall to Boston Scientific’s RotaWire Elite Guidewire and wireClip Torquer Guidewire

Last month, the FDA issued a Class I recall to Boston Scientific’s RotaWire Elite Guidewire and wireClip Torquer Guidewire because the core wires may crack and separate from the rest of the Rotablator Rotational Atherectomy System.  This device is used to open narrowed arteries and improve blood flow to the heart, when patients undergo atherectomy [...]

By | December 1st, 2015|Drug and Medical Device Litigation|Comments Off on FDA Issues Class I Recall to Boston Scientific’s RotaWire Elite Guidewire and wireClip Torquer Guidewire

FDA Announces recall on OmniPod Insulin Management System Units

The FDA announced on August 27 that the Insulet Corporation initiated a voluntary recall of some of its OmniPod Insulin Management System units.  This is due to the possibility that certain lots of the OmniPod may have a higher rate of failure.  This can happen when a cannula completely retracts or fails to fully deploy, [...]

By | August 28th, 2015|Drug and Medical Device Litigation, OmniPod|Comments Off on FDA Announces recall on OmniPod Insulin Management System Units

Johnson and Johnson Again Leads Big Pharma in 2014 Revenues

J&J, who has seemingly survived the DePuy wars and is now facing down 22,000 vaginal mesh suits after losing mesh verdicts for its Ethicon product again leads the way in profits for Big Pharma in 2014, according to Tracy Staton writing in Fierce Pharma. Click here to read the full article: The Top 15 Pharma Companies [...]

By | March 30th, 2015|Drug and Medical Device Litigation|Comments Off on Johnson and Johnson Again Leads Big Pharma in 2014 Revenues

Big PHARMA Spends $4.58 Billion in Direct to Consumer Ads in 2014

Whenever you watch the news, or a sporting event, does it ever seem like there are a lot of ads for drugs? For that special moment there are Cialis and Viagra and a host of other things that nice looking people suffering various maladies suddenly get better in a 30 to 60 second span while [...]

By | March 27th, 2015|Drug and Medical Device Litigation|Comments Off on Big PHARMA Spends $4.58 Billion in Direct to Consumer Ads in 2014

Johnson & Johnson Pleads Guilty for Metal-Tainted Children’s Tylenol and Ordered to Pay $25 Million Fine

McNeil-PPC, Inc., a subsidiary of pharma giant Johnson & Johnson, pleaded guilty on March 10, 2015 for violating the federal Food, Drug and Cosmetic Act (FDCA) with regard to infants' and children's liquid medications, including Infants' Tylenol, Children's Tylenol and Children's Motrin.  The company has pleaded guilty to a federal misdemeanor charge and will pay [...]

By | March 17th, 2015|Drug and Medical Device Litigation|Comments Off on Johnson & Johnson Pleads Guilty for Metal-Tainted Children’s Tylenol and Ordered to Pay $25 Million Fine

Second November 2014 Huge Mesh Loss for Boston Scientific

On November 20, 2014, a jury in Charleston, West Virginia Federal court found the Massachusetts Company liable to four women following a 10-day trial and determined damages for each of the four women ranging from $3.25 million to $4.25 million for the injuries.  The women used the company’s Obtryx device (Obtryx Transobturator Mid-Urethral Sling System) [...]

By | November 21st, 2014|Drug and Medical Device Litigation, Transvaginal Mesh|Comments Off on Second November 2014 Huge Mesh Loss for Boston Scientific

$27 Million Dollar Mesh Verdict Against Boston Scientific

A Federal jury in Miami, Florida awarded $27 million to four women who were injured by defective mesh product manufactured by Boston Scientific.  Boston Scientific will not face additional punitive damages.  The jury returned a verdict finding negligence by Boston Scientific with the Pinnacle Pelvic Floor Repair Kit.  The jury found that this product was [...]

By | November 18th, 2014|Drug and Medical Device Litigation, Transvaginal Mesh|Comments Off on $27 Million Dollar Mesh Verdict Against Boston Scientific

Dallas Jury Awards $73 Million TVM Verdict against Boston Scientific

In the first victory for plaintiffs against Boston Scientific Corp. and their mesh devices, a Dallas, Texas jury found for the plaintiff Martha Salazar and ordered Boston Scientific to pay a staggering $73 million.  Jurors found Boston Scientific to be at fault for the damages that Ms. Salazar suffered as well as a finding of [...]

By | September 10th, 2014|Drug and Medical Device Litigation, Transvaginal Mesh|Comments Off on Dallas Jury Awards $73 Million TVM Verdict against Boston Scientific